x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
THE SECURITIES EXCHANGE ACT OF 1934 |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from | to |
Florida | No. 59-1517485 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
Large accelerated filer x | Accelerated filer o | |
Non-accelerated filer o (Do not check if a smaller reporting company) | Smaller reporting company o | |
Emerging growth company o |
INDEX | |||
PAGE | |||
PART I | |||
Item 1. | |||
Condensed Consolidated Statements of Financial Condition as of December 31, 2017 and September 30, 2017 (Unaudited) | |||
Condensed Consolidated Statements of Income and Comprehensive Income for the three months ended December 31, 2017 and December 31, 2016 (Unaudited) | |||
Condensed Consolidated Statements of Changes in Shareholders’ Equity for the three months ended December 31, 2017 and December 31, 2016 (Unaudited) | |||
Condensed Consolidated Statements of Cash Flows for the three months ended December 31, 2017 and December 30, 2016 (Unaudited) | |||
Note 1 - Organization and basis of presentation | |||
Note 2 - Update of significant accounting policies | |||
Note 3 - Acquisitions | |||
Note 4 - Fair value | |||
Note 5 - Available-for-sale securities | |||
Note 6 - Derivative financial instruments | |||
Note 7 - Collateralized agreements and financings | |||
Note 8 - Bank loans, net | |||
Note 9 - Variable interest entities | |||
Note 10 - Goodwill and identifiable intangible assets, net | |||
Note 11 - Bank deposits | |||
Note 12 - Other borrowings | |||
Note 13 - Income taxes | |||
Note 14 - Commitments, contingencies and guarantees | |||
Note 15 - Accumulated other comprehensive income/(loss) | |||
Note 16 - Interest income and interest expense | |||
Note 17 - Share-based and other compensation | |||
Note 18 - Regulatory capital requirements | |||
Note 19 - Earnings per share | |||
Note 20 - Segment information | |||
Item 2. | |||
Item 3. | |||
Item 4. | |||
PART II | |||
Item 1. | |||
Item 1A. | |||
Item 2. | Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities | ||
Item 3. | |||
Item 4. | Mine Safety Disclosure | ||
Item 5. | |||
Item 6. | |||
$ in thousands, except per share amounts | December 31, 2017 | September 30, 2017 | ||||||
Assets: | ||||||||
Cash and cash equivalents | $ | 3,897,529 | $ | 3,669,672 | ||||
Assets segregated pursuant to regulations and other segregated assets | 3,569,414 | 3,476,085 | ||||||
Securities purchased under agreements to resell | 307,742 | 404,462 | ||||||
Securities borrowed | 184,971 | 138,319 | ||||||
Financial instruments, at fair value: | ||||||||
Trading instruments (includes $302,713 and $357,099 pledged as collateral) | 597,579 | 564,263 | ||||||
Available-for-sale securities | 2,393,321 | 2,188,282 | ||||||
Derivative assets | 292,140 | 318,775 | ||||||
Private equity investments | 189,033 | 198,779 | ||||||
Other investments (includes $38,591 and $6,640 pledged as collateral) | 265,170 | 220,980 | ||||||
Brokerage client receivables, net | 2,666,268 | 2,766,771 | ||||||
Receivables from brokers, dealers and clearing organizations | 219,036 | 268,021 | ||||||
Other receivables | 642,542 | 652,769 | ||||||
Bank loans, net | 17,697,298 | 17,006,795 | ||||||
Loans to financial advisors, net | 890,072 | 873,272 | ||||||
Investments in real estate partnerships held by consolidated variable interest entities | 110,662 | 111,743 | ||||||
Property and equipment, net | 454,115 | 437,374 | ||||||
Deferred income taxes, net | 199,507 | 313,486 | ||||||
Goodwill and identifiable intangible assets, net | 651,339 | 493,183 | ||||||
Other assets | 857,161 | 780,425 | ||||||
Total assets | $ | 36,084,899 | $ | 34,883,456 | ||||
Liabilities and equity: | ||||||||
Bank deposits | $ | 18,725,545 | $ | 17,732,362 | ||||
Securities sold under agreements to repurchase | 229,036 | 220,942 | ||||||
Securities loaned | 290,307 | 383,953 | ||||||
Financial instruments sold but not yet purchased, at fair value: | ||||||||
Trading instruments | 213,024 | 221,449 | ||||||
Derivative liabilities | 356,505 | 356,964 | ||||||
Brokerage client payables | 5,820,347 | 5,411,829 | ||||||
Payables to brokers, dealers and clearing organizations | 189,144 | 172,714 | ||||||
Accrued compensation, commissions and benefits | 793,687 | 1,059,996 | ||||||
Other payables | 582,548 | 567,045 | ||||||
Other borrowings | 1,532,826 | 1,514,012 | ||||||
Senior notes payable | 1,548,975 | 1,548,839 | ||||||
Total liabilities | 30,281,944 | 29,190,105 | ||||||
Commitments and contingencies (see Note 14) | ||||||||
Equity | ||||||||
Preferred stock; $.10 par value; 10,000,000 shares authorized; -0- shares issued and outstanding | — | — | ||||||
Common stock; $.01 par value; 350,000,000 shares authorized; 155,497,352 and 154,228,235 shares issued as of December 31, 2017 and September 30,2017, respectively, and 145,153,686 and 144,096,521 shares outstanding as of December 31, 2017 and September 30, 2017, respectively | 1,555 | 1,542 | ||||||
Additional paid-in capital | 1,705,308 | 1,645,397 | ||||||
Retained earnings | 4,420,368 | 4,340,054 | ||||||
Treasury stock, at cost; 10,311,191 and 10,084,038 common shares as of December 31, 2017 and September 30, 2017, respectively | (410,029 | ) | (390,081 | ) | ||||
Accumulated other comprehensive loss | (20,454 | ) | (15,199 | ) | ||||
Total equity attributable to Raymond James Financial, Inc. | 5,696,748 | 5,581,713 | ||||||
Noncontrolling interests | 106,207 | 111,638 | ||||||
Total equity | 5,802,955 | 5,693,351 | ||||||
Total liabilities and equity | $ | 36,084,899 | $ | 34,883,456 |
Three months ended December 31, | ||||||||
$ in thousands, except per share amounts | 2017 | 2016 | ||||||
Revenues: | ||||||||
Securities commissions and fees | $ | 1,103,566 | $ | 984,385 | ||||
Investment banking | 64,902 | 61,425 | ||||||
Investment advisory and related administrative fees | 142,023 | 108,243 | ||||||
Interest | 231,729 | 182,782 | ||||||
Account and service fees | 184,301 | 148,791 | ||||||
Net trading profit | 19,870 | 20,555 | ||||||
Other | 19,201 | 22,587 | ||||||
Total revenues | 1,765,592 | 1,528,768 | ||||||
Interest expense | (39,431 | ) | (35,966 | ) | ||||
Net revenues | 1,726,161 | 1,492,802 | ||||||
Non-interest expenses: | ||||||||
Compensation, commissions and benefits | 1,152,767 | 1,006,467 | ||||||
Communications and information processing | 83,731 | 72,161 | ||||||
Occupancy and equipment costs | 49,814 | 46,052 | ||||||
Business development | 33,793 | 35,362 | ||||||
Investment sub-advisory fees | 22,321 | 19,295 | ||||||
Bank loan loss provision/(benefit) | 1,016 | (1,040 | ) | |||||
Acquisition-related expenses | 3,927 | 12,666 | ||||||
Other | 67,108 | 94,324 | ||||||
Total non-interest expenses | 1,414,477 | 1,285,287 | ||||||
Income including noncontrolling interests and before provision for income taxes | 311,684 | 207,515 | ||||||
Provision for income taxes | 192,401 | 59,812 | ||||||
Net income including noncontrolling interests | 119,283 | 147,703 | ||||||
Net income attributable to noncontrolling interests | 441 | 1,136 | ||||||
Net income attributable to Raymond James Financial, Inc. | $ | 118,842 | $ | 146,567 | ||||
Earnings per common share – basic | $ | 0.82 | $ | 1.03 | ||||
Earnings per common share – diluted | $ | 0.80 | $ | 1.00 | ||||
Weighted-average common shares outstanding – basic | 144,469 | 142,110 | ||||||
Weighted-average common and common equivalent shares outstanding – diluted | 148,261 | 145,675 | ||||||
Net income attributable to Raymond James Financial, Inc. | $ | 118,842 | $ | 146,567 | ||||
Other comprehensive income/(loss), net of tax: (1) | ||||||||
Unrealized loss on available-for-sale securities and non-credit portion of other-than-temporary impairment losses | (11,953 | ) | (4,146 | ) | ||||
Unrealized gain/(loss) on currency translations, net of the impact of net investment hedges | (187 | ) | 1,001 | |||||
Unrealized gain on cash flow hedges | 6,885 | 25,738 | ||||||
Total comprehensive income | $ | 113,587 | $ | 169,160 |
(1) | All components of other comprehensive income/(loss), net of tax, are attributable to Raymond James Financial, Inc. |
Three months ended December 31, | ||||||||
$ in thousands, except per share amounts | 2017 | 2016 | ||||||
Common stock, par value $.01 per share: | ||||||||
Balance, beginning of year | $ | 1,542 | $ | 1,513 | ||||
Share issuances | 13 | 17 | ||||||
Balance, end of period | 1,555 | 1,530 | ||||||
Additional paid-in capital: | ||||||||
Balance, beginning of year | 1,645,397 | 1,498,921 | ||||||
Employee stock purchases | 5,522 | 4,743 | ||||||
Exercise of stock options and vesting of restricted stock units, net of forfeitures | 20,953 | 18,969 | ||||||
Restricted stock, stock option and restricted stock unit expense | 33,373 | 30,971 | ||||||
Other | 63 | (322 | ) | |||||
Balance, end of period | 1,705,308 | 1,553,282 | ||||||
Retained earnings: | ||||||||
Balance, beginning of year | 4,340,054 | 3,834,781 | ||||||
Net income attributable to Raymond James Financial, Inc. | 118,842 | 146,567 | ||||||
Cash dividends declared | (38,417 | ) | (34,274 | ) | ||||
Other | (111 | ) | — | |||||
Balance, end of period | 4,420,368 | 3,947,074 | ||||||
Treasury stock: | ||||||||
Balance, beginning of year | (390,081 | ) | (362,937 | ) | ||||
Purchases/surrenders | (7,183 | ) | (8,474 | ) | ||||
Exercise of stock options and vesting of restricted stock units, net of forfeitures | (12,765 | ) | (16,458 | ) | ||||
Balance, end of period | (410,029 | ) | (387,869 | ) | ||||
Accumulated other comprehensive loss: (1) | ||||||||
Balance, beginning of year | (15,199 | ) | (55,733 | ) | ||||
Net change in unrealized loss on available-for-sale securities and non-credit portion of other-than-temporary impairment losses, net of tax | (11,953 | ) | (4,146 | ) | ||||
Net change in currency translations and net investment hedges, net of tax | (187 | ) | 1,001 | |||||
Net change in cash flow hedges, net of tax | 6,885 | 25,738 | ||||||
Balance, end of period | (20,454 | ) | (33,140 | ) | ||||
Total equity attributable to Raymond James Financial, Inc. | $ | 5,696,748 | $ | 5,080,877 | ||||
Noncontrolling interests: | ||||||||
Balance, beginning of year | $ | 111,638 | $ | 146,431 | ||||
Net income attributable to noncontrolling interests | 441 | 1,136 | ||||||
Capital contributions | — | 4,998 | ||||||
Distributions | (5,977 | ) | (26,557 | ) | ||||
Other | 105 | (2,284 | ) | |||||
Balance, end of period | 106,207 | 123,724 | ||||||
Total equity | $ | 5,802,955 | $ | 5,204,601 |
RAYMOND JAMES FINANCIAL, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) | ||||||||
Three months ended December 31, | ||||||||
$ in thousands | 2017 | 2016 | ||||||
Cash flows from operating activities: | ||||||||
Net income attributable to Raymond James Financial, Inc. | $ | 118,842 | $ | 146,567 | ||||
Net income attributable to noncontrolling interests | 441 | 1,136 | ||||||
Net income including noncontrolling interests | 119,283 | 147,703 | ||||||
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 23,289 | 19,941 | ||||||
Deferred income taxes | 121,273 | 10,928 | ||||||
Premium and discount amortization on available-for-sale securities and unrealized gain on other investments | (496 | ) | (10,185 | ) | ||||
Provisions for loan losses, legal and regulatory proceedings and bad debts | 9,265 | 33,017 | ||||||
Share-based compensation expense | 34,417 | 32,572 | ||||||
Compensation expense payable in common stock of an acquiree | 3,925 | 7,973 | ||||||
Unrealized gain on company owned life insurance, net of expenses | (16,859 | ) | (5,088 | ) | ||||
Other | 5,693 | (5,724 | ) | |||||
Net change in: | ||||||||
Assets segregated pursuant to regulations and other segregated assets | (96,759 | ) | 1,006,933 | |||||
Securities purchased under agreements to resell, net of securities sold under agreements to repurchase | 104,290 | 120,393 | ||||||
Securities loaned, net of securities borrowed | (140,229 | ) | (232,438 | ) | ||||
Loans provided to financial advisors, net of repayments | (21,928 | ) | (14,554 | ) | ||||
Brokerage client receivables and other accounts receivable, net | 123,512 | 83,887 | ||||||
Trading instruments, net | (46,547 | ) | 152,474 | |||||
Derivative instruments, net | 30,449 | 38,447 | ||||||
Other assets | (18,799 | ) | 84,289 | |||||
Brokerage client payables and other accounts payable | 466,763 | (481,542 | ) | |||||
Accrued compensation, commissions and benefits | (266,453 | ) | (216,889 | ) | ||||
Proceeds from sales of securitizations and loans held for sale, net of purchases and originations of loans held for sale | (108,470 | ) | 35,162 | |||||
Net cash provided by operating activities | 325,619 | 807,299 | ||||||
Cash flows from investing activities: | ||||||||
Additions to property, buildings and equipment, including software | (35,949 | ) | (78,371 | ) | ||||
Increase in bank loans, net | (645,197 | ) | (774,376 | ) | ||||
Proceeds from sales of loans held for investment | 21,580 | 54,163 | ||||||
Purchases of available-for-sale securities | (339,580 | ) | (377,235 | ) | ||||
Available-for-sale securities maturations, repayments and redemptions | 114,139 | 56,647 | ||||||
Proceeds from sales of available-for-sale securities | — | 7,308 | ||||||
Business acquisition, net of cash acquired | (159,200 | ) | — | |||||
Other investing activities, net | (29,669 | ) | 17,124 | |||||
Net cash used in investing activities | (1,073,876 | ) | (1,094,740 | ) | ||||
(continued on next page) | ||||||||
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited). |
RAYMOND JAMES FINANCIAL, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (continued from previous page) | ||||||||
Three months ended December 31, | ||||||||
$ in thousands | 2017 | 2016 | ||||||
Cash flows from financing activities: | ||||||||
Proceeds from borrowings on the RJF Credit Facility | 300,000 | — | ||||||
Proceeds from/(repayments of) short-term borrowings, net | (280,000 | ) | 208,400 | |||||
Proceeds from Federal Home Loan Bank advances | — | 100,000 | ||||||
Repayments of Federal Home Loan Bank advances and other borrowed funds | (1,186 | ) | (1,138 | ) | ||||
Exercise of stock options and employee stock purchases | 25,954 | 24,143 | ||||||
Increase in bank deposits | 993,183 | 927,243 | ||||||
Purchases of treasury stock | (20,243 | ) | (26,058 | ) | ||||
Dividends on common stock | (32,499 | ) | (31,255 | ) | ||||
Distributions to noncontrolling interests, net | (5,977 | ) | (26,557 | ) | ||||
Net cash provided by financing activities | 979,232 | 1,174,778 | ||||||
Currency adjustment: | ||||||||
Effect of exchange rate changes on cash | (3,118 | ) | (9,514 | ) | ||||
Net increase in cash and cash equivalents | 227,857 | 877,823 | ||||||
Cash and cash equivalents at beginning of year | 3,669,672 | 1,650,452 | ||||||
Cash and cash equivalents at end of period | $ | 3,897,529 | $ | 2,528,275 | ||||
Supplemental disclosures of cash flow information: | ||||||||
Cash paid for interest | $ | 28,026 | $ | 32,442 | ||||
Cash paid for income taxes | $ | 8,515 | $ | 13,710 |
• | Requires equity investments (other than those accounted for under the equity method or those that result from the consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any. |
• | Simplifies the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment. |
• | Eliminates the requirement to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet. |
• | Requires the use of the exit price notion when measuring the fair value of financial instruments for disclosure purposes. |
• | Requires an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option. |
• | Requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (that is, securities or loans and receivables) on the balance sheet or the accompanying notes to the financial statements. |
• | Clarifies that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale securities in combination with the entity’s other deferred tax assets. |
• | Expands the ability to hedge nonfinancial and financial risk components. |
• | Reduces complexity in fair value hedges of interest rate risk. |
• | Eliminates the requirement to separately measure and report hedge ineffectiveness. |
• | Generally requires the entire change in the fair value of a hedging instrument to be presented in the same income statement line as the hedged item. |
• | Modifies accounting for components excluded from the assessment of hedge effectiveness. |
• | Eases certain documentation and hedge effectiveness assessment requirements. |
Three months ended December 31, | ||||||||
$ in thousands | 2017 | 2016 | ||||||
Legal and regulatory | $ | 2,281 | $ | 553 | ||||
Severance | 990 | 4,803 | ||||||
Information systems integration costs | 162 | 1,205 | ||||||
Acquisition and integration-related incentive compensation costs | — | 5,474 | ||||||
Early termination costs of assumed contracts | — | 1,324 | ||||||
Post-closing purchase price contingency | — | (2,251 | ) | |||||
All other | 494 | 1,558 | ||||||
Total acquisition-related expenses | $ | 3,927 | $ | 12,666 |
$ in thousands | Quoted prices in active markets for identical instruments (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Netting adjustments | Balance as of December 31, 2017 | |||||||||||||||
Assets at fair value on a recurring basis | ||||||||||||||||||||
Trading instruments | ||||||||||||||||||||
Municipal and provincial obligations | $ | 122 | $ | 197,580 | $ | — | $ | — | $ | 197,702 | ||||||||||
Corporate obligations | 11,069 | 33,723 | — | — | 44,792 | |||||||||||||||
Government and agency obligations | 6,376 | 17,929 | — | — | 24,305 | |||||||||||||||
Agency mortgage-backed securities (“MBS”) and collateralized mortgage obligations (“CMOs”) | 2,128 | 214,680 | — | — | 216,808 | |||||||||||||||
Non-agency CMOs and asset-backed securities (“ABS”) | — | 52,244 | 5 | — | 52,249 | |||||||||||||||
Total debt securities | 19,695 | 516,156 | 5 | — | 535,856 | |||||||||||||||
Equity securities | 18,497 | 803 | — | — | 19,300 | |||||||||||||||
Brokered certificates of deposit | — | 32,173 | — | — | 32,173 | |||||||||||||||
Other | 27 | 7,511 | 2,712 | — | 10,250 | |||||||||||||||
Total trading instruments | 38,219 | 556,643 | 2,717 | — | 597,579 | |||||||||||||||
Available-for-sale securities | ||||||||||||||||||||
Agency MBS and CMOs | — | 2,285,051 | — | — | 2,285,051 | |||||||||||||||
Other securities | 787 | — | — | — | 787 | |||||||||||||||
Auction rate securities (“ARS”) preferred securities | — | — | 107,483 | — | 107,483 | |||||||||||||||
Total available-for-sale securities | 787 | 2,285,051 | 107,483 | — | 2,393,321 | |||||||||||||||
Derivative assets | ||||||||||||||||||||
Interest rate contracts | ||||||||||||||||||||
Matched book | — | 263,851 | — | — | 263,851 | |||||||||||||||
Other | — | 58,660 | — | (30,375 | ) | 28,285 | ||||||||||||||
Foreign exchange contracts | — | 4 | — | — | 4 | |||||||||||||||
Total derivative assets | — | 322,515 | — | (30,375 | ) | 292,140 | ||||||||||||||
Private equity investments (1) | ||||||||||||||||||||
Not measured at NAV | — | — | 88,810 | — | 88,810 | |||||||||||||||
Measured at NAV | 100,223 | |||||||||||||||||||
Total private equity investments | — | — | 88,810 | — | 189,033 | |||||||||||||||
Other investments (2) | 263,978 | 859 | 333 | — | 265,170 | |||||||||||||||
Total assets at fair value on a recurring basis | $ | 302,984 | $ | 3,165,068 | $ | 199,343 | $ | (30,375 | ) | $ | 3,737,243 | |||||||||
Assets at fair value on a nonrecurring basis | ||||||||||||||||||||
Bank loans, net | ||||||||||||||||||||
Impaired loans | $ | — | $ | 16,347 | $ | 23,418 | $ | — | $ | 39,765 | ||||||||||
Loans held for sale (3) | — | 69,057 | — | — | 69,057 | |||||||||||||||
Total assets at fair value on a nonrecurring basis | $ | — | $ | 85,404 | $ | 23,418 | $ | — | $ | 108,822 | ||||||||||
(continued on next page) |
(continued from previous page) | ||||||||||||||||||||
$ in thousands | Quoted prices in active markets for identical instruments (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Netting adjustments | Balance as of December 31, 2017 | |||||||||||||||
Liabilities at fair value on a recurring basis | ||||||||||||||||||||
Trading instruments sold but not yet purchased | ||||||||||||||||||||
Municipal and provincial obligations | $ | 742 | $ | 3,082 | $ | — | $ | — | $ | 3,824 | ||||||||||
Corporate obligations | 608 | 7,394 | — | — | 8,002 | |||||||||||||||
Government obligations | 183,510 | — | — | — | 183,510 | |||||||||||||||
Agency MBS and CMOs | 328 | — | — | — | 328 | |||||||||||||||
Non-agency MBS and CMOs | — | — | — | — | — | |||||||||||||||
Total debt securities | 185,188 | 10,476 | — | — | 195,664 | |||||||||||||||
Equity securities | 16,294 | 4 | — | — | 16,298 | |||||||||||||||
Other | 4 | — | 1,058 | — | 1,062 | |||||||||||||||
Total trading instruments sold but not yet purchased | 201,486 | 10,480 | 1,058 | — | 213,024 | |||||||||||||||
Derivative liabilities | ||||||||||||||||||||
Interest rate contracts | ||||||||||||||||||||
Matched book | — | 263,851 | — | — | 263,851 | |||||||||||||||
Other | — | 86,815 | — | (42,284 | ) | 44,531 | ||||||||||||||
Foreign exchange contracts | — | 19,710 | — | — | 19,710 | |||||||||||||||
Deutsche Bank restricted stock unit (“DBRSU”) obligation (equity) | — | 28,413 | — | — | 28,413 | |||||||||||||||
Total derivative liabilities | — | 398,789 | — | (42,284 | ) | 356,505 | ||||||||||||||
Total liabilities at fair value on a recurring basis | $ | 201,486 | $ | 409,269 | $ | 1,058 | $ | (42,284 | ) | $ | 569,529 |
(1) | Of the total private equity investments, the portion we owned was $138 million as of December 31, 2017. The portion of the private equity investments we did not own was $51 million as of December 31, 2017 and was included as a component of noncontrolling interests in our Condensed Consolidated Statements of Financial Condition. |
(2) | Includes $45 million of financial instruments that are related to obligations to perform under certain deferred compensation plans and Deutsche Bank AG (“DB”) shares with a fair value of $21 million as of December 31, 2017 which we hold as an economic hedge against the DBRSU obligation. See Notes 2 and 20 in our 2017 Form 10-K for additional information. |
(3) | Loans classified as held for sale recorded at a fair value lower than cost. |
$ in thousands | Quoted prices in active markets for identical instruments (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Netting adjustments | Balance as of September 30, 2017 | |||||||||||||||
Assets at fair value on a recurring basis | ||||||||||||||||||||
Trading instruments | ||||||||||||||||||||
Municipal and provincial obligations | $ | 83 | $ | 221,884 | $ | — | $ | — | $ | 221,967 | ||||||||||
Corporate obligations | 9,361 | 81,577 | — | — | 90,938 | |||||||||||||||
Government and agency obligations | 6,354 | 28,977 | — | — | 35,331 | |||||||||||||||
Agency MBS and CMOs | 913 | 133,070 | — | — | 133,983 | |||||||||||||||
Non-agency CMOs and ABS | — | 28,442 | 5 | — | 28,447 | |||||||||||||||
Total debt securities | 16,711 | 493,950 | 5 | — | 510,666 | |||||||||||||||
Equity securities | 16,090 | 389 | — | — | 16,479 | |||||||||||||||
Brokered certificates of deposit | — | 31,492 | — | — | 31,492 | |||||||||||||||
Other | 32 | — | 5,594 | — | 5,626 | |||||||||||||||
Total trading instruments | 32,833 | 525,831 | 5,599 | — | 564,263 | |||||||||||||||
Available-for-sale securities | ||||||||||||||||||||
Agency MBS and CMOs | — | 2,081,079 | — | — | 2,081,079 | |||||||||||||||
Other securities | 1,032 | — | — | — | 1,032 | |||||||||||||||
ARS preferred securities | — | — | 106,171 | — | 106,171 | |||||||||||||||
Total available-for-sale securities | 1,032 | 2,081,079 | 106,171 | — | 2,188,282 | |||||||||||||||
Derivative assets | ||||||||||||||||||||
Interest rate contracts | ||||||||||||||||||||
Matched book | — | 288,035 | — | — | 288,035 | |||||||||||||||
Other | — | 86,436 | — | (55,728 | ) | 30,708 | ||||||||||||||
Foreign exchange contracts | — | 32 | — | — | 32 | |||||||||||||||
Total derivative assets | — | 374,503 | — | (55,728 | ) | 318,775 | ||||||||||||||
Private equity investments (1) | ||||||||||||||||||||
Not measured at NAV | — | — | 88,885 | — | 88,885 | |||||||||||||||
Measured at NAV | 109,894 | |||||||||||||||||||
Total private equity investments | — | — | 88,885 | — | 198,779 | |||||||||||||||
Other investments (2) | 220,312 | 332 | 336 | — | 220,980 | |||||||||||||||
Total assets at fair value on a recurring basis | $ | 254,177 | $ | 2,981,745 | $ | 200,991 | $ | (55,728 | ) | $ | 3,491,079 | |||||||||
Assets at fair value on a nonrecurring basis | ||||||||||||||||||||
Bank loans, net | ||||||||||||||||||||
Impaired loans | $ | — | $ | 17,474 | $ | 23,994 | $ | — | $ | 41,468 | ||||||||||
Loans held for sale (3) | — | 11,285 | — | — | 11,285 | |||||||||||||||
Total bank loans, net | — | 28,759 | 23,994 | — | 52,753 | |||||||||||||||
Other assets: other real estate owned | — | 880 | — | — | 880 | |||||||||||||||
Total assets at fair value on a nonrecurring basis | $ | — | $ | 29,639 | $ | 23,994 | $ | — | $ | 53,633 | ||||||||||
(continued on next page) |
(continued from previous page) | ||||||||||||||||||||
$ in thousands | Quoted prices in active markets for identical instruments (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Netting adjustments | Balance as of September 30, 2017 | |||||||||||||||
Liabilities at fair value on a recurring basis | ||||||||||||||||||||
Trading instruments sold but not yet purchased | ||||||||||||||||||||
Municipal and provincial obligations | $ | 304 | $ | — | $ | — | $ | — | $ | 304 | ||||||||||
Corporate obligations | 1,286 | 35,272 | — | — | 36,558 | |||||||||||||||
Government obligations | 167,622 | — | — | — | 167,622 | |||||||||||||||
Agency MBS and CMOs | 2,477 | — | — | — | 2,477 | |||||||||||||||
Non-agency MBS and CMOs | — | 5,028 | — | — | 5,028 | |||||||||||||||
Total debt securities | 171,689 | 40,300 | — | — | 211,989 | |||||||||||||||
Equity securities | 8,118 | 1,342 | — | — | 9,460 | |||||||||||||||
Total trading instruments sold but not yet purchased | 179,807 | 41,642 | — | — | 221,449 | |||||||||||||||
Derivative liabilities | ||||||||||||||||||||
Interest rate contracts | ||||||||||||||||||||
Matched book | — | 288,035 | — | — | 288,035 | |||||||||||||||
Other | — | 101,893 | — | (59,410 | ) | 42,483 | ||||||||||||||
Foreign exchange contracts | — | 646 | — | — | 646 | |||||||||||||||
DBRSU obligation (equity) | — | 25,800 | — | — | 25,800 | |||||||||||||||
Total derivative liabilities | — | 416,374 | — | (59,410 | ) | 356,964 | ||||||||||||||
Total liabilities at fair value on a recurring basis | $ | 179,807 | $ | 458,016 | $ | — | $ | (59,410 | ) | $ | 578,413 |
(1) | Of the total private equity investments, the portion we owned was $145 million as of September 30, 2017. The portion of the private equity investments we did not own was $54 million as of September 30, 2017, and was included as a component of noncontrolling interests in our Condensed Consolidated Statements of Financial Condition. |
(2) | Includes $44 million of financial instruments that are related to obligations to perform under certain deferred compensation plans and DB shares with a fair value of $19 million as of September 30, 2017, which we hold as an economic hedge against the DBRSU obligation. See Notes 2 and 20 in our 2017 Form 10-K for additional information. |
(3) | Loans classified as held for sale recorded at a fair value lower than cost. |
Three months ended December 31, 2017 Level 3 instruments at fair value | ||||||||||||||||||||||||
Financial assets | Financial liabilities | |||||||||||||||||||||||
Trading instruments | Available-for-sale securities | Private equity and other investments | Trading instruments | |||||||||||||||||||||
$ in thousands | Non-agency CMOs & ABS | Other | ARS - preferred securities | Private equity investments | Other investments | Other | ||||||||||||||||||
Fair value beginning of period | $ | 5 | $ | 5,594 | $ | 106,171 | $ | 88,885 | $ | 336 | $ | — | ||||||||||||
Total gains/(losses) for the period | ||||||||||||||||||||||||
Included in earnings | — | (1,207 | ) | — | 2 | (3 | ) | (1,058 | ) | |||||||||||||||
Included in other comprehensive income | — | — | 1,312 | — | — | — | ||||||||||||||||||
Purchases and contributions | — | 20,279 | — | — | — | — | ||||||||||||||||||
Sales | — | (21,954 | ) | — | (77 | ) | — | — | ||||||||||||||||
Distributions | — | — | — | — | — | — | ||||||||||||||||||
Transfers | ||||||||||||||||||||||||
Into Level 3 | — | — | — | — | — | — | ||||||||||||||||||
Out of Level 3 | — | — | — | — | — | — | ||||||||||||||||||
Fair value end of period | $ | 5 | $ | 2,712 | $ | 107,483 | $ | 88,810 | $ | 333 | $ | (1,058 | ) | |||||||||||
Unrealized gains/(losses) for the period included in earnings for instruments held at the end of the reporting period | $ | — | $ | (243 | ) | $ | 1,312 | $ | — | $ | (3 | ) | $ | (1,058 | ) |
Three months ended December 31, 2016 Level 3 instruments at fair value | ||||||||||||||||||||||||||||
Financial assets | Financial liabilities | |||||||||||||||||||||||||||
Trading instruments | Available-for-sale securities | Private equity and other investments | Trading instruments | |||||||||||||||||||||||||
$ in thousands | Non-agency CMOs & ABS | Other | ARS – municipals obligations | ARS - preferred securities | Private equity investments | Other investments | Other | |||||||||||||||||||||
Fair value beginning of period | $ | 7 | $ | 6,020 | $ | 25,147 | $ | 100,018 | $ | 83,165 | $ | 441 | $ | — | ||||||||||||||
Total gains/(losses) for the period | ||||||||||||||||||||||||||||
Included in earnings | — | (2,589 | ) | — | 1 | 301 | (8 | ) | (1,792 | ) | ||||||||||||||||||
Included in other comprehensive income | — | — | 217 | 3,857 | — | — | — | |||||||||||||||||||||
Purchases and contributions | — | 18,683 | — | — | — | — | — | |||||||||||||||||||||
Sales | — | (11,062 | ) | — | (23 | ) | — | (15 | ) | — | ||||||||||||||||||
Distributions | — | — | — | — | — | — | — | |||||||||||||||||||||
Transfers | ||||||||||||||||||||||||||||
Into Level 3 | — | — | — | — | — | — | — | |||||||||||||||||||||
Out of Level 3 | — | — | — | — | — | (195 | ) | — | ||||||||||||||||||||
Fair value end of period | $ | 7 | $ | 11,052 | $ | 25,364 |